News

The program will include over 3,000 diabetic patients and will evaluate a once-a-day injection of AVE0010/ZP10 in combination with the principal existing treatments (metformin, sulfonylurea, insulin), as well

The product will be marketed under store brand labels and is comparable to Johnson & Johnson – Merck Consumer Pharmaceutical’s Pepcid Complete, an acid reducer plus antacid medication

The recalled patches all have expiration dates on or before December 2009, and all are manufactured by Alza, an affiliate of PriCara. The recall is being conducted in

The $2.30 million in aggregate principal amount of senior convertible notes to be issued in the financing will bear interest annually at a rate of eight percent per

OmegaMaine Omega-3 oil is an all natural, high potency, liquid fish oil that has been formulated to decrease inflammation, the root cause of periodontal diseases. The company claims

The new round of funding will be used to facilitate the company’s future electronic-negotiation event cycles through 2008, continue to expand the depth of its leadership team and

This prospective, non-randomized clinical trial is expected to enroll approximately 70 patients at 10 medical centers in the US. The primary efficacy endpoints for the trial are patients

General Atlantic previously acquired a 52% majority interest in Emdeon Business Services from HLTH in November 2006. In the November 2006 transaction, HLTH received approximately $1.2 billion in

Richard Colonno, chief scientific officer of Presidio, said: “Numerate has a very promising computational approach that we believe will help expand our HCV portfolio in a highly competitive